S125: NON-GENETIC RESISTANCE TO MENIN INHIBITION IN AML IS REVERSIBLE BY PERTURBATION OF KAT6A

類似資料

• The MLL–Menin Interaction is a Therapeutic Vulnerability in NUP98-rearranged AML
  著者:: Milad Rasouli, 等
  出版事項: (2023-08-01)
• Targeting of epigenetic co-dependencies enhances anti-AML efficacy of Menin inhibitor in AML with MLL1-r or mutant NPM1
  著者:: Warren Fiskus, 等
  出版事項: (2023-04-01)
• Correction: Targeting of epigenetic co-dependencies enhances anti-AML efficacy of Menin inhibitor in AML with MLL1-r or mutant NPM1
  著者:: Warren Fiskus, 等
  出版事項: (2025-05-01)
• PB1761: PRECLINICAL EVALUATION OF THE MENIN INHIBITOR ZIFTOMENIB IN PRIMARY AML SPECIMENS
  著者:: Brett Stevens, 等
  出版事項: (2023-08-01)
• The small inhibitor WM-1119 effectively targets KAT6A-rearranged AML, but not KMT2A-rearranged AML, despite shared KAT6 genetic dependency
  著者:: Mathew Sheridan, 等
  出版事項: (2024-10-01)